40
Participants
Start Date
January 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
May 31, 2027
ESPB
Participants will receive ultrasound-guided ESPB preoperatively, using 40 ml of 0.3% ropivacaine.
PCA
Participants will receive postoperative PCA with a formulation of 200 µg sufentanil diluted to 100 ml. The PCA settings will include a background dose of 3 ml/hour, a lockout time of 15 minutes, and a bolus dose of 2 ml.
West China Hospital, Sichuan University, Chengdu
West China Hospital
OTHER